| __timestamp | Bausch Health Companies Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 13673000 |
| Thursday, January 1, 2015 | 582800000 | 14358000 |
| Friday, January 1, 2016 | 455000000 | 12203000 |
| Sunday, January 1, 2017 | 366000000 | 18125000 |
| Monday, January 1, 2018 | 414000000 | 17071000 |
| Tuesday, January 1, 2019 | 471000000 | 20018000 |
| Wednesday, January 1, 2020 | 452000000 | 32788000 |
| Friday, January 1, 2021 | 465000000 | 44966000 |
| Saturday, January 1, 2022 | 529000000 | 311681000 |
| Sunday, January 1, 2023 | 604000000 | 77707000 |
Unlocking the unknown
In the ever-evolving landscape of healthcare, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Bausch Health Companies Inc. and Lantheus Holdings, Inc. have demonstrated contrasting approaches to R&D investment.
Bausch Health has consistently allocated a significant portion of its resources to R&D, with expenditures peaking in 2023 at approximately 604 million USD, marking a 146% increase from 2014. This commitment underscores their focus on expanding their pharmaceutical and medical device offerings.
Conversely, Lantheus Holdings, Inc. has shown a more conservative R&D strategy. Despite a notable surge in 2022, where spending reached around 312 million USD, their overall investment remains modest compared to Bausch Health. This strategic choice may reflect a focus on optimizing existing products and technologies.
These divergent strategies highlight the varied paths companies take in the pursuit of innovation and market leadership.
Research and Development Investment: Eli Lilly and Company vs Bausch Health Companies Inc.
R&D Spending Showdown: Amgen Inc. vs Lantheus Holdings, Inc.
Research and Development Investment: Sanofi vs Bausch Health Companies Inc.
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Lantheus Holdings, Inc.
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Analyzing R&D Budgets: Veracyte, Inc. vs Bausch Health Companies Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Mesoblast Limited
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.